Rubicon Research IPO Listing, Share Price Live Updates: Rubicon Research is a pharmaceutical formulation company with a strong focus on R&D and innovation. Its portfolio includes an increasing number of speciality products and drug-device combination products targeting regulated markets, particularly the United States.

The company has also been expanding its manufacturing footprint. In June, it acquired Alkem Laboratories' formulations facility in Pithampur, Madhya Pradesh, in an all-cash deal worth Rs 149 crore.

It currently operates two US FDA-inspected R&D facilities -- one in India and another in Canada -- along with two manufacturing plants in India accredited by multiple regulatory authorities, including USFDA, Maharashtra FDA (WHO-GMP), and Health Canada.

Rubicon Research IPO Listing, Share Price Live Updates: Proceeds from the fresh issue to the tune of ₹310 crore would be used for debt repayment, and a portion would be allocated for inorganic growth through acquisitions, strategic initiatives, and general corporate purposes.

Rubicon Research IPO Listing, Share Price Live Updates: Shares of Rubicon Research are down 1% to ₹614 on the NSE after starting trading 27.84% higher than the issue price.

• Traded Volume (Lakhs): 198.21
• Traded Value (₹ Cr.): 1,216.47
• Total Market Cap (₹ Cr.): 10,175.80

Rubicon Research IPO Listing, Share Price Live Updates: Shares of Rubicon Research are trading 1% higher at ₹626 apiece on the NSE after listing at a 27.84% premium.

• Current price: ₹608.55 (-1.85%)
• Issue price: ₹485
• Open: ₹620
• High: ₹620
• Low: ₹587.35

Rubicon Research IPO Listing, Share Price Live Updates: The market capitalisation of Rubicon Research stands at ₹9,921.26 as the stock is down 2.78% to ₹602.6 apiece on the NSE.

Rubicon Research IPO Listing, Share Price Live Updates: Shares of Rubicon Research are trading 3.2% lower at ₹600.15 apiece on the NSE after the stock listed at a 27.84% premium.

Rubicon Research IPO Listing, Share Price Live Updates: The unlisted shares of Rubicon Research are trading at ₹630, reflecting a grey market premium (GMP) of 29.90% over the upper price band of ₹485.

Rubicon Research IPO Listing, Share Price Live Updates: The price bad was set between ₹461 and ₹485 per share.

Rubicon Research IPO Listing, Share Price Live Updates: Rubicon Research shares will be listed under the 'RUBICON' symbol on the NSE and the BSE.

Rubicon Research IPO Listing, Share Price Live Updates: Rubicon Research Ltd's shares will debut on the secondary market - the NSE and the BSE - on Thursday, October 16, at 10 am.

Rubicon Research IPO Listing, Share Price Live Updates: The shares of pharmaceutical player Rubicon Research will be listed on the NSE and BSE on Thursday, October 16.